• IDS 2020

    Beijing China, October 15-18

  • IDS 2020

    Beijing China, October 15-18

  • IDS 2020

    Beijing China, October 15-18

  • IDS 2020

    Beijing China, October 15-18

  • IDS 2020

    Beijing China, October 15-18

  • IDS 2020

    Beijing China, October 15-18

Program

17th IDS Congress Preliminary Agenda V3

Day 1  (Oct 15, 2020)

19:00-19:10

(Beijing time)

Opening Ceremony: Anette Ziegler (Germany, 13:00) & Zhiguang Zhou (China) 

19:10-19:35

Franco Bottazzo Lecture (25')

Ake Lernmark (Sweden, 13:10

Chair

Ezio Bonifacio (Germany, 13:10)

19:35-20:50

Session  1 Epigenetics and Transcriptomics of T1D  ( 75 min )

Key Note Lecture :David Leslie (UK, 12:35) 15' 

Epigenetics of T1D: Epiphany or Epiphenomenon?

Chairs  :

Carani Sanjeevi (Sweden, 13:35), Linda Yip (USA, 4:35am)

Speakers:(15' each)

Ranjeny Thomas (Queensland, Australia, 21:35): Identification and therapeutic regulation of autoantigen-specific responses in pediatric type 1 diabetes)

Cong-Yi Wang (China): The implication of epigenetic factors in the initiation and progression of type 1 diabetes

Riitta Lahesmaa (Finland, 13:35): Early detection of immune cell signatures in children developing beta-cell autoimmunity

Questions: 15min

20:50-21:00

BREAK 10 min

21:00-22:15

Session  2 Genetic Risk and Heterogeneity of T1D  ( 75min )

Key Note Lecture Steve Rich (USA, 9:00 am)25' 

Advances in the Genetic Basis of Type 1 Diabetes and Application to Population Screening

Chairs  :A G Ziegler (Germany, 15:00) Bill Hagopian (USA, 6:00am)

S peakers:(15' each)

Tao Yang (China) Characteristics and heterogeneity of genetics, autoimmune and islet function for adult-onset type 1 diabetes

Andrea Steck (USA, 7:00am): Heterogeneity and Prediction of T1D

William Hagopian (USA, 6:00am): Applying Combined Risk Scores using Genetics, Family History and Islet Autoantibodies in Pediatric Population Screening and Selection for Prevention Trials

Questions: 20min

CLOSE OF SESSION 22:15  Total 3 hours  15min

Day 2  (Oct 16, 2020)

19:00-20:30

Session  3  Beta cell in Health and Disease  ( 90 min )

Key Note Lecture

Tao Xu (China ) 25'

Chairs

Zhou Z (China) , Decio Eizirik (Belgium, 13:00)

Speaker s (15'each)

Helen Thomas (Australia, 21:00): The influence of cytokines and JAK inhibitors on expansion of antigen-specific T cells

Stephan Speier (Germany, 13:00): In Situ Analysis of Human Islet Pathophysiology in T1D

Teresa Mastracci (USA, 7:00am)

Questions: 20min

20:30-20:40

BREAK 10 min

20:40-21:25

Session  4 Gut  M icrobiota in T1D ( 45 min )

Chairs

Li Wen (USA, 8:40am) James Pearson (UK, 13:40)

Discussant Emma Hamilton-Williams (Australia, 22:40)

Speakers (15'  each )

Michael Knip (U Helsinki, Finland, 14:40): Can the T1D Risk Be Modulated Through the Intestinal Microbiome?

Yu Liu (China)

Questions: 15 min

21:25-22:15

Session  5 Adult-Onset Autoimmune Diabetes  ( 50min )

Chairs

David Leslie (UK, 14:25), Zhiguang Zhou (China)

Discussants Toshiaki Hanafusa (Japan, 22:25), Paolo Pozzilli (Italy, 15:25)

Speakers (15' each)

Xia Li (China)

Tiina Tuomi (Finland, 15:25)

Questions: 20min

CLOSE OF SESSION 2 2 : 1 5  Total  3  hours  1 5 min

Day 3  (Oct 17, 2020)

19:00-20:00

Session  6 Islet Transplantation  & Stem Cell Therapy (60 min)

Chair s

Tom Kay (Australia, 21:00) Susan Wong (UK, 12:00)

Discussant Philip O'Connell (Australia, 21:00)

Speakers (15' each)

Akihisa Imagawa (Japan, 20:00): Usefulness of patient-derived iPS cells in fulminant type 1 diabetes

Hongkui Deng (China)

Qizhi Tang (USA, 4:00am): Islet-infiltrating Tregs in autoimmune diabetes and islet transplantation

Questions: 15 min

20:00-20:25

George Eisenbarth Lecture  (25')

Kevan Herold (USA, 8:00am)

Chairs

AG Ziegler (Germany, 14:00)

Marian Rewers (USA, 7:00am)

20:25-20:35 

BREAK 10 min

20:35-22:10

Session  7 Immune Cells in T1D  ( 95 min )

Chairs

Mark Peakman (UK, 13:35), Yufei Xiang (USA, 5:35am

Speakers (15' each)

Roberto Mallone (France, 14:35):βeauty is in the eye of the T-cell beholder

Peggy Kendall (USA, 7:35am): Targeting anti-insulin B cells in T1D

Aimin Xu (China): Neutrophil-macrophage crosstalk in autoimmune diabetes

Agnes Lehuen (INSERM, U Paris, France, 14:35): MAIT cells at the crossroad between microbiota, inflammation and metabolism

Questions: 20 min

22:10-22:55

Session  8 Immune Therapy (45 min)

Chair s Jay Skyler (USA, 9:10am) Chantal Mathieu (Belgium, 16:10)

Speakers (15' each)

Colin Dayan (UK, 15:10): JDRF TOMI and the way forward in beta cell preservation in T1D

David Rawlings (USA, 7:10am): Gene editing to generation engineered regulatory T cells for treatment of autoimmune disorders including T1D

Questions: 15 min

CLOSE OF SESSION 22:55  Total 3 hours 55min

Day 4  (Oct 18, 2020)

19:00-20:10

Session 9 Autoimmunity:  Advances in  I mmunology (70min)

Key Note Lecture

Chen Dong (China) 25'

CD4+ T cells in autoimmunity

Chairs

Dirk Homann (Germany, 13:00) Z Zhou (China)

Discussant Lucienne Chatenoud (France, 13:00)

Speakers (15' each)

Tetsuro Kobayashi (Japan, 20:00): Distinct pathological changes of the pancreas in slowly progressive type 1 (insulin-dependent) diabetes

Abdu Hamad (USA, 7:00am)

Questions: 15min

20:10-20:20

BREAK 10min

20:20-22:20

S pecial session incorporating  w orkshops

20:20-21:20

T cell workshop  (60 ' )


21:20-22:20

Antibody Workshop IASP  60'

CLOSE OF SESSION 22: 20  Total 3 hours  20min


Time

0400 West coast USA

0500 Mountain time USA

0600 Central USA

0700 Eastern USA

1200 UK

1300 Europe

1900 China

2000 Japan

2100 Melbourne, Sydney, Australia